Please assess the completion status of the following clinical trial:

Trial Title: Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Hospitalized patients in the ICU or the RNF with acute LGIB (defined as maroon-colored stool or bright red blood per rectum with suspicion of acute blood loss anemia, and hemodynamically stable and/or stabilized at the time of procedure . Hospitalized patients include:~  * Patients who develop LGIB while admitted for different reasons~ * Patients transferred from an outside hospital for further management of acute LGIB~ * Patients admitted through the emergency room for management of acute LGIB~* At least 22 years old~* Undergoing urgent colonoscopy under monitored anesthesia care or conscious sedation~Exclusion Criteria:~* Suspicion for bowel obstruction/ stricture~* Toxic megacolon or severe colitis (determined by degree of colitis on imaging and clinical condition including pain, fevers, abdominal exam, elevated inflammatory markers)~* Active Diverticulitis

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pure-Vu Treatment (Type: EXPERIMENTAL): Participants in this arm will undergo colonoscopy using the Pure-Vu cleansing device.

Based on this trial design, predict the completion outcome and termination type (if applicable).